Key Clinical Summary: Prophylaxis Decision-Making in Mild and Moderate Hemophilia A
Added 15 Dec 2025
The Future of Sickle Cell Disease Care 2025
30th - 31st Oct 2025, 11:30pm (GMT)
Free, Online
The Future of Sickle Cell Disease Care 2025: Expert Roundtable
Duration: 1hr 2m 44s
2 months ago
Joint Care Access Brief: Supporting Early Prophylaxis in Mild–Moderate Hemophilia A
Joint Care Conversation Guide for Mild to Moderate Hemophilia A
Joint Protection Pathways in Mild to Moderate Hemophilia A: Integrating prophylaxis timing, personalization, and joint surveillance
Latest Advances in Hemophilia A Joint Care
15th Oct 2025, 9:30pm (GMT)
Hemophilia A Care: Tools and strategies for early joint health surveillance and intervention
Duration: 21m 25s
4 months ago
Hemophilia A Care: Personalizing treatment with PK, activity level, and bleeding risk in mind
Duration: 11m 51s
Hemophilia A Care: When and why to initiate Factor VIII prophylaxis in mild/moderate Hemophilia A
Duration: 18m 53s
Integrating PROs & HRQoL for Personalized Sickle Cell Care: Key Clinical Summary
Updated 4 Aug 2025
Strengthening the Sickle Cell Disease Triad: Key Clinical Summary
Monitoring and Managing Progressive Organ Dysfunction in Sickle Cell Disease (SCD): Key Clinical Summary
Evolving the Treatment Paradigm for Sickle Cell Disease: Key Clinical Summary
Strengthening the Sickle Cell Disease Triad
Duration: 17m 4s
5 months ago
Transforming Sickle Cell Disease in 2025: The Patient Perspective
Duration: 39m 8s
Applying PROs to Guide Personalized Sickle Cell Disease Care
Duration: 15m 50s
Managing Long-Term Organ Dysfunction in Sickle cell Disease
Duration: 22m 52s
Emerging Therapies & Multimodal Approaches for Sickle Cell Disease
Duration: 19m 42s
